Skip to content
Review

Connecting mechanistic roles of vitamins in dementia: An overview on translational insights from preclinical models to clinical promise.

Jul 2026 · Ageing Research Reviews · Vol 121, pp. 103262 · 0 citations · 329 references
Medicine

TL;DR

Whether these potential vitamins have an adjunctive role in delaying or preventing neurodegenerative disease is examined, and optimizing vitamin levels in the body may present a promising, multifaceted role for the management of dementia and related CNS disorders.

Abstract

Dementia, a progressive neurodegenerative disorder, is a primary cause of disability and dependence in the elderly. It has become prevalent worldwide, affecting more than 55 million people. This increasing epidemiological and mechanistic evidence indicates that neuroinflammation, mitochondrial dysfunction, oxidative stress, and neurotransmitter levels are solely related to the disease pathophysiology. Essential micronutrients, such as lipid and water-soluble vitamins, have been identified as potential neuroprotective substances due to their multiple important biochemical roles in maintaining the integrity and functioning of neurons. These oil and water-soluble vitamins (Vitamin A-K) support several important activities of the central nervous system, including the synthesis of neurotransmitters, antioxidant activity, neuroprotective role, and regulation of inflammation, lipid metabolism, and gene expression, all of which are essential in maintaining brain function and neural plasticity. Therefore, the purpose of this review is to critically evaluate the molecular mechanisms by which these vitamins provide neuroprotection as evident in the literature, in both preclinical models and clinical studies. Additionally, this review examines whether these potential vitamins have an adjunctive role in delaying or preventing neurodegenerative disease. Conclusively, optimizing vitamin levels in the body may present a promising, multifaceted role for the management of dementia and related CNS disorders.

View source

Similar papers

Review Aug 2026

The potential of vitamins in Huntington’s disease: bridging mechanistic evidence with translational limitations and future strategies

How the vitamins’ potential is at stake to reach the clinical perspective is highlighted, along with different strategies to overcome their limitations using novel drug delivery and biomarker-based approaches.

V. Padole, Yogesh A. Kulkarni · 0 citations
Review Open access Sep 2026

DHA in Alzheimer's Disease: The translational gap between mechanistic complexity and clinical inconsistency.

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive dysfunction. Docosahexaenoic acid (DHA), the most abundant ω-3 polyunsaturated fatty acid (PUFA) in the brain, is essential for neuronal structure and function. Although epidemiological studies generally associate higher DHA...

Xin-Hua Li, Yue Jin, Xiao-Yu Li et al. · 0 citations
Review Open access Sep 2026

The Role of Curcumin in Neurogenesis and Neuroprotection in Alzheimer’s disease: From Molecular Mechanisms to Clinical Evidence

This review discusses multi-target neuroprotective mechanisms of curcumin, critically reviews the preclinical success and human clinical trial outcomes, and highlights advanced nano formulations (solid lipid nanoparticles, colloidal sub-micron dispersions, polymeric nanoparticles, multi-walled carbon nanotubes and exos...

V. S, Sarupruthiya M, Jeevitha D et al. · 0 citations
Review Open access Sep 2026

Protective Potentials of Natural Products Against Vascular Dementia: A Comprehensive Review of Experimental Studies.

Vascular dementia (VaD), accounting for up to 20% of dementia cases globally, is primarily driven by chronic cerebral hypoperfusion (CCH), which leads to progressive cognitive impairment. Despite the increasing prevalence of VaD, effective treatments remain limited. Natural products-including herbal formulas, single he...

Jung-Hoon Kim, Yongtaek Oh, Suin Cho · 0 citations
Review Oct 2026

Intermittent Fasting as a Therapeutic Strategy in Alzheimer's Disease: Understanding of Brain-Derived Neurotrophic Factor Modulation.

Alzheimer's disease (AD) is a progressive neurodegenerative disease with amyloid-beta (Aβ) plaques, tau tangles, neuroinflammation, and oxidative stress, and it causes cognitive impairment and neuronal loss. The pharmacological treatment is of limited effectiveness, therefore the interest in novel approaches such as in...

Dnyaneshwar S. Shrirame, Amol A. Tatode, Dhiraj Dabhade et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.